Diabetic muscle infarction (DMI) is a rare complication that often exists in long-standing diabetic patients. Clinically, it presents with pain, swelling and sometimes a palpable mass, and is often misdiagnosed as soft tissue infection. The athogenesis of DMI is uncertain. We present the case of a type 2 diabetic patient with liver cirrhosis who was diagnosed with muscle infarction after being treated with terlipressin for gastrointestinal bleeding. This 45-year-old male complained of increasing pain in his right posterior thigh after treatment with terlipressin for 2 days. He was initially diagnosed with soft tissue infection, but he responded poorly to antibiotic treatment. Magnetic resonance imaging suggested acute muscle infarction. We performed a muscle biopsy and the pathologist reported that the muscle was necrotic. After 5 days of bed rest, the patient was able to walk and was discharged uneventfully.
Diabetic muscle infarction (DMI) is an underrecognized diabetic complication characterized by muscle pain and swelling. It usually occurs in subjects with long-standing diabetes and known microvascular complications. There are no useful biochemical markers for this disease and it can easily be misdiagnosed as soft tissue infection. The exact pathogenesis of DMI is unclear. This case report presents a type 2 diabetic patient who was diagnosed with DMI after being treated with terlipressin for gastrointestinal bleeding.
CASE PRESENTATION
This 45-year-old male had been diagnosed with type 2 diabetes with nephropathy, retinopathy and neuropathy. He was also known to have hepatitis C-related liver cirrhosis and had experienced several episodes of esophageal varices and gastric ulcer bleeding prior to admission. On this occasion, he was brought to our hospital due to another episode of hematemesis. The patient refused gastroenteroscopy and his gastrointestinal bleeding was therefore treated with pantoprazole and terlipressin. After treatment for 2 days, he complained of increasing pain in his right posterior thigh. Physical examinations revealed a tender and swollen mass over his right posterior thigh. Laboratory data showed a white blood cell count of 8990/μL, C-reactive protein of 26.6 ng/mL, creatine phosphokinase of 359 U/L, and an erythrocyte sedimentation rate of 107 mm/hr. A soft tissue infection was initially suspected, for which he was treated with antibiotics. Because he responded poorly, we arranged for magnetic resonance imaging (MRI) ( Figure 1 ). The radiologist strongly suspected that the patient could have acute muscle infarction, but that a muscle abscess could not be ruled out. To make an accurate diagnosis, we performed a muscle biopsy, and the pathologist reported that the muscle was necrotic ( Figure 2 ). No microorganisms were detected. Based on these findings, the patient was diagnosed with DMI. Antibiotic treatment was discontinued and complete bed rest was advised. After 5 days hospitalization, the patient was able to walk and was discharged.
DISCUSSION
Angervall and Stener reported the first case of DMI in 1965 [1] . Since then, slightly more than 100 cases have been reported in the English literature. DMI usually occurs in patients with long-standing diabetes, especially type 1 diabetes, with known late complications such as nephropathy, retinopathy, or neuropathy [2] . There is a slight female predominance and the mean age at presentation is about 43 years [2, 3] . The most commonly involved sites are the quadriceps (62%), hip adductors (13%), hamstrings (8%), and hip flexor muscles (2%) [4] .
Typical presentations of DMI include acute onset pain in the affected muscle, local swelling, and sometimes a palpable mass. Local heat and erythematous appearance are not usually found on examination of the skin. The diagnosis must be differentiated from muscle strain, hematoma, myositis, fasciitis, abscess, deep vein thrombosis, and thrombophlebitis [5] . There are no useful biochemical markers for this disease, though increased plasma levels of creatine phosphokinase, a raised erythrocyte sedimentation rate, and raised leukocyte count might alert physicians of the possibility of DMI [2, 3] . However, because these abnormalities are nonspecific and easily ignored, it is easy to initially misdiagnose DMI as soft tissue infection.
Nearly all patients with DMI have abnormal findings on MRI. Swollen and edematous muscles demonstrate increased signal intensity on T2-weighted, post-gadolinium sequences [6] . MRI also makes it possible to exclude other diseases that mimic DMI. Sonography is an alternative diagnostic tool; classic findings include a well-marginated, hypoechoic, intramuscular lesion with features of internal linear echogenic structures coursing through the lesion [7] . DMI can be confirmed by muscle biopsy. Light microscopy will show irregular areas of hemorrhaging, muscle necrosis, and the appearance of granular tissue and collagen. Replacement of necrotic muscle fibers by fibrous tissue, myocyte regeneration, and mononuclear cell infiltration occurs in the late stages [8] . Although a definite diagnosis can be made by performing a muscle biopsy, this should be reserved for atypical cases [3, 8] .
The main treatment strategy includes bed rest and pain relief with analgesics. Surgical excision is not recommended because it extends the length of hospital stay and has been associated with higher recurrence and mortality compared with nonsurgical treatment [9] . Symptoms usually resolve in approximately 4-8 weeks, though in nearly 50% of these patients, the disease may recur [4] . The long-term prognosis is generally poor, due to the coexistence of lethal macrovascular diseases. The mean mortality is 10% within 2 years from the onset of DMI [2] .
The pathogenesis of DMI remains unclear. Some authors have suggested that it results from ischemia caused by embolization of atheromatous material [1, 10] . However, arteriosclerosis obliterans has also been thought to be responsible [11] . Some authors have shown that alterations in the coagulation-fibrinolysis system and antiphospholipid syndrome might be involved [12, 13] . In this case report, the patient developed DMI after being treated with terlipressin, a potent vasoconstrictor. Some reports in the literature have associated the use of terlipressin with serious cardiovascular events and ischemic colitis [14, 15] . In this case, no abnormalities in the patient's coagulation system or phospholipid antibodies were detected during treatment, and magnetic resonance angiography of the affected leg revealed intact vascularity. Thus, it is probable that the vasoconstrictive effect of terlipressin worsened the blood flow in the affected muscles. Because the blood supply was impaired, the affected muscle swelled, leading to mild compartment syndrome, which further worsened the ischemia and resulted in muscle necrosis.
In summary, we report the first case of DMI probably caused by terlipressin. This report suggests that clinicians should be alert to the possibility of DMI when using vasoconstrictors in diabetic patients, especially those who are in the late stages of the disease and therefore often have compromised blood circulation. 
